Thrivent Financial for Lutherans
ASND icon

Thrivent Financial for Lutherans’s Ascendis Pharma A/S ASND Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-35,941
Closed -$4.95M – 2363
2024
Q4 		$4.95M Sell
35,941
-42,532
-54% -$5.59M 0.01% 914
2024
Q3 		$11.7M Buy
78,473
+228
+0.3% +$30.8K 0.02% 628
2024
Q2 		$10.7M Sell
78,245
-36,156
-32% -$4.92M 0.02% 642
2024
Q1 		$17.3M Buy
114,401
+1,137
+1% +$162K 0.03% 502
2023
Q4 		$14.3M Sell
113,264
-2,190
-2% -$218K 0.03% 523
2023
Q3 		$10.8M Buy
115,454
+1,502
+1% +$141K 0.03% 580
2023
Q2 		$10.2M Sell
113,952
-13,164
-10% -$1.15M 0.02% 641
2023
Q1 		$13.6M Buy
127,116
+1,918
+2% +$219K 0.03% 524
2022
Q4 		$15.3M Buy
125,198
+2,270
+2% +$264K 0.04% 480
2022
Q3 		$12.7M Sell
122,928
-13,051
-10% -$1.24M 0.03% 518
2022
Q2 		$12.6M Sell
135,979
-10,252
-7% -$966K 0.03% 531
2022
Q1 		$17.2M Sell
146,231
-3,326
-2% -$385K 0.03% 516
2021
Q4 		$20.1M Sell
149,557
-4,802
-3% -$714K 0.04% 467
2021
Q3 		$24.6M Sell
154,359
-25,244
-14% -$3.45M 0.05% 401
2021
Q2 		$23.6M Buy
179,603
+13,642
+8% +$1.82M 0.05% 409
2021
Q1 		$21.4M Buy
+165,961
New +$25.2M 0.05% 426

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Thrivent Financial for Lutherans's ASND Position: Q1 2025 in Review

Thrivent Financial for Lutherans sold out of Ascendis Pharma A/S (ASND) in Q1 2025, closing a stake of 35,941 shares — an estimated $4.95M sold.

Thrivent Financial for Lutherans first reported a position in ASND in Q1 2021 and held it in 16 quarters. The position peaked at $24.6M in Q3 2021. 244 funds tracked by Wall St. Rank hold ASND as of Q1 2025.

  • Thrivent Financial for Lutherans reported no remaining Ascendis Pharma A/S position as of Q1 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 35,941 Ascendis Pharma A/S shares in Q1 2025, an estimated $4.95M.
  • Thrivent Financial for Lutherans first reported a position in Ascendis Pharma A/S in Q1 2021 and held it in 16 quarters.
  • Thrivent Financial for Lutherans's Ascendis Pharma A/S position peaked at $24.6M in Q3 2021.
  • 244 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2025, filed 13 May 2025.